Latest News

Orly Vardeny, PharmD: Finerenone for Heart Failure with EF >40% in FINEARTS-HF | Image Credit: JACC Journals
Orly Vardeny, PharmD, MS: Finerenone for Heart Failure with EF >40% in FINEARTS-HF

December 14th 2024

Orly Vardeny, PharmD, MS explores the efficacy of nonsteroidal MRAs in heart failure with mildly reduced or preserved ejection fraction in the FINE-ARTS trial.

Matthew J. Budoff, MD: Impact of Obesity on Cardiometabolic Health in T1D | Image Credit: The Lundquist Institute
Matthew J. Budoff, MD: Impact of Obesity on Cardiometabolic Health in T1D

December 14th 2024

FDA Approves Crinecerfont for Congenital Adrenal Hyperplasia | Image Credit: US Food and Drug Administration
FDA Approves Crinecerfont for Congenital Adrenal Hyperplasia

December 13th 2024

Jennifer B. Green, MD: Implementation of Evidence-Based Therapies for T2D | Image Credit: Duke University
Jennifer B. Green, MD: Implementation of Evidence-Based Therapies for T2D

December 13th 2024

Upadacitinib Sustained Efficacy, Safety Among Patients with Atopic Dermatitis Over 188 Weeks
Upadacitinib Sustained Efficacy, Safety Among Patients with Atopic Dermatitis Over 188 Weeks

December 13th 2024

Lungcast
Don’t Miss a Beat
Diabetes Dialogue
New Insight with Dr. Veeral Sheth
Crisis Point

Conference Coverage

View All
Orly Vardeny, PharmD: Finerenone for Heart Failure with EF >40% in FINEARTS-HF | Image Credit: JACC Journals
Orly Vardeny, PharmD, MS: Finerenone for Heart Failure with EF >40% in FINEARTS-HF

December 14th 2024

Matthew J. Budoff, MD: Impact of Obesity on Cardiometabolic Health in T1D | Image Credit: The Lundquist Institute
Matthew J. Budoff, MD: Impact of Obesity on Cardiometabolic Health in T1D

December 14th 2024

Jennifer B. Green, MD: Implementation of Evidence-Based Therapies for T2D | Image Credit: Duke University
Jennifer B. Green, MD: Implementation of Evidence-Based Therapies for T2D

December 13th 2024

Ralph A. DeFronzo, MD: Noxious Nine and Mifepristone for Hypercortisolism in T2D | Image Credit: LinkedIn
Ralph A. DeFronzo, MD: Noxious Nine and Mifepristone for Hypercortisolism in T2D

December 13th 2024

Video Series
Video Interviews
Podcasts
2024 State of Lung Cancer: The Hopes and Hurdles of Precision Oncology with Jacob Sands, MD
How to Manage Aspirin-Exacerbated Respiratory Disease
Medical Ethics Unpacked: Ethical Considerations for Euthanasia and Medically-Assisted Suicide
Medical Ethics Unpacked:
Diabetes Dialogue: Tirzepatide’s Long-Term Obesity Data | Image Credit: HCPLive
Diabetes Dialogue: Latest Updates on Semaglutide Shortage, Data | Image Credit: HCPLive
Physician, Patient, and Partner Perspectives on AERD with Mitchell Grayson, MD, Rhonda Nelson, and Wayne Nelson

All News

© 2024 MJH Life Sciences

All rights reserved.